EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD

Sebastian Marciniak, Weronika Wasyluk, Andrzej Wojtak

Acta Biochimica Polonica · 2025

DOI: 10.3389/abp.2025.15251 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biochimica Polonica, 2025. Verfasst von Sebastian Marciniak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland. Hauptthemen laut MEDLINE: Epilepsy, Cannabinoids, Anticonvulsants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, cannabinoids and their derivatives have been tested for efficacy in epilepsy therapy and related disorders. Many of them may help alleviate ailments associated with seizures. An in-depth study of cannabinoid derivatives and the receptors on which they operate give us a chance for more effective use of these substances in epilepsy therapy. Many studies point to the beneficial synergy of cannabinoids with chemotherapeutics and the increase in effectiveness of the latter. As a result, both alternatives to drug treatment and support for the pharmacotherapy are being developed. In this review, we focused on compounds such as Δ9-THC, CBDV, Δ9-THCA, Δ9-THCV, H2CBD and their receptors as well as on CBD’s actions, and the enzymes, ion channels, and transporters engaged in the fundamental causes of epileptic seizures. Treating epilepsy and drug-resistant epilepsy are the two common medical uses of cannabinoids. We looked at approximately 150 current scientific articles from peer-reviewed journals to explore the molecular effects of cannabinoids in these applications. Our goal was to improve physician awareness of factors influencing treatment decisions and potential adverse reactions to minimize medical errors and optimize patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyCannabinoidsAnticonvulsantsHumansAnimalsReceptors, Cannabinoid

Stichwörter der Autor:innen

CBDCBDVcannabinoidsepilepsyΔ9-THCΔ9-THCA

Substanzen

CannabinoidsAnticonvulsantsReceptors, Cannabinoid

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
  • Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
  • Chair and Department of Vascular Surgery and Angiology, Medical University of Lublin, Lublin, Poland.

Zitieren

APA

Marciniak, S., Wasyluk, W., & Wojtak, A. (2025). Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD. Acta Biochimica Polonica. https://doi.org/10.3389/abp.2025.15251

Vancouver

Marciniak S, Wasyluk W, Wojtak A. Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD. Acta Biochimica Polonica. 2025. doi:10.3389/abp.2025.15251

BibTeX
@article{Marciniak2025,
  author = {Marciniak, Sebastian and Wasyluk, Weronika and Wojtak, Andrzej},
  title = {Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD},
  journal = {Acta Biochimica Polonica},
  year = {2025},
  doi = {10.3389/abp.2025.15251}
}
Kostenlos starten →